-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Buy on PTC Therapeutics, Lowers Price Target to $93

Benzinga·02/20/2026 12:40:31
Listen to the news
B of A Securities analyst Tazeen Ahmad maintains PTC Therapeutics (NASDAQ:PTCT) with a Buy and lowers the price target from $97 to $93.